Suggested

Trending

Ecaterina Dumbrava, MD on Phase I Trial of COM701: What Tumor Types are Affected? @MDAndersonNews
0:01:34

Ecaterina Dumbrava, MD on Phase I Trial of COM701: What Tumor Types are Affected? @MDAndersonNews
5 Views
4 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
AACR Presentations Highlight Preclinical Efficacy of Imipridones in Molecularly-Selected Tumors

AACR Presentations Highlight Preclinical Efficacy of Imipridones in Molecularly-Selected Tumors
Other Free
7 Views
1 week ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Phase III KEYNOTE-522 Trial KEYTRUDA #SABCS
0:04:14

Phase III KEYNOTE-522 Trial KEYTRUDA #SABCS
98 Views
5 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
AbbVie Receives Positive CHMP Opinion for VENCLYXTO® as a Chemotherapy-Free Combination Regimen for Patients with Previously Untreated Chronic Lymphocytic Leukemia

AbbVie Receives Positive CHMP Opinion for VENCLYXTO® as a Chemotherapy-Free Combination Regimen for Patients with Previously Untreated Chronic Lymphocytic Leukemia
5 Views
4 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Latest Videos

Eva Domingo-Domenech, MD on ADCETRIS: Why Are Targeted Therapies Important in Treating sALCL?
0:01:35

Eva Domingo-Domenech, MD on ADCETRIS: Why Are Targeted Therapies Important in Treating sALCL?
Other Free
0 Views
9 hours ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Eva Domingo-Domenech, MD on How ADCETRIS May Impact Existing Treatment in sALCL?
0:01:27

Eva Domingo-Domenech, MD on How ADCETRIS May Impact Existing Treatment in sALCL?
Other Free
0 Views
9 hours ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Eva Domingo-Domenech, MD on ADCETRIS for Treatment with Previously Untreated sALCL
0:01:13

Eva Domingo-Domenech, MD on ADCETRIS for Treatment with Previously Untreated sALCL
Other Free
0 Views
9 hours ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Charles Rudin, MD on KEYNOTE-604: How Does This Compare to Other Trials? #ASCO2020 @charlesrudin #ASCO @sloan_kettering
0:02:00

Charles Rudin, MD on KEYNOTE-604: How Does This Compare to Other Trials? #ASCO2020 @charlesrudin #ASCO @sloan_kettering
6 Views
1 day ago
Want to watch this again later?
Sign in to add this video to a playlist. Login